United States Ketoprofen Market Report 2016

Published On:November 23, 2016, 11:59 am

Ketoprofen in a non-steroidal anti-inflammatory agent (NSAIA) with antipyretic and analgesic properties and has pharmacologic actions very similar to the other archetypical NSAIDs, which hamper prostaglandin synthesis. Ketoprofen is used for the treatment of inflammation, fever, rheumatoid arthritis, osteoarthritis, dysmenorrheal, and to reduce the intensity of moderate pain. Also, for the purpose of diagnostic treatment of chronic and acute rheumatoid arthritis, ankylosing spondylitis, primary dysmenorrheal and pain associated with musculotendinous trauma (sprains and strains), postpartum pain, and postoperative (including dental surgery). Ketoprofen works by reducing the hormones which cause pain and inflammation inside the body. It also acts on cyclooxygenase enzyme, which reduces the levels of prostaglandin chemicals which are responsible for fever, pain, etc. However, ketoprofen possesses several side effects such as nausea, headaches, stomach pain, and loss of appetite, vomiting, indigestion, and liver associated problems. This drug also increases the chances of fatal blood vessels and heart attack or stroke, particularly with prolonged higher usage. Therefore, this medicine is strictly avoided prior to a heart bypass surgery. A few medicines like ACE inhibitors, pentoxifylline, warfarin, aspirin, ciclosporin and methotrexate interact with ketoprofen resulting in several kinds of complications such as lithium toxicity, or might lower the blood pressure.

To Request Sample Copy of This Report: http://www.qyresearchgroups.com/request-sample/163360

The United States Ketoprofen market is predicted to witness a substantial growth while growing at a lucrative CAGR during the forecast period owing to the constant increase in the geriatric population. Other factors like expanding healthcare expenditure and surging sedentary lifestyle, together is propelling this industry’s market in the United States. Moreover, there has been a noticeable increase in the number of people suffering from bone and joint disorders; this coupled with increasing prevalence of obese people is driving the market of ketoprofen to a positive growth. Escalation in the number of surgeries performed along with budding healthcare awareness amongst people is fuelling the growth of the United States ketoprofen market. Nonetheless, stringent regulatory measures for the approval of the drug and the possible side effects of ketoprofen are a few key factors restricting the growth of ketoprofen in United States.

Wider application of ketoprofen will help in developing new opportunities for the United States ketoprofen market. Nevertheless, introduction of new therapeutic analgesics along with herbal products might prove to be a challenge for this industry’s market. Some of the major market players involved in the United States ketoprofen market are Sanofi, Boehringer Ingelheim, Zhejiang Jiuzhou, Schein Pharmaceutical, and Hubei Xunda.

Research Assistance Research Assistance

We will be happy to help you find what you need. Please write to us: